A

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Associate Director - Corporate Financial Planning & Analysis

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-time$170k - $185k

About the Job

Requirements

  • A bachelor's degree in Finance, Accounting, Economics, or a related field is required.
  • At least 10 years of progressive FP&A experience, including at least 5 years in a leadership role, is required.
  • Proficiency in Microsoft Excel and experience building models are required.
  • Ability to gather, analyze, and interpret information for completeness and accuracy is required.
  • Strong attention to detail and organizational skills are required.
  • Ability to communicate effectively with people at all levels, internally and externally, and tailor communication to the audience to achieve desired results is required.
  • Ability to work independently in a fast-paced environment with minimal supervision is required.
  • Experience with FP&A planning systems is required.
  • Working knowledge of Generally Accepted Accounting Principles (US GAAP) is required.

Responsibilities

  • Partner with the Head of FP&A to support enterprise-wide financial planning and corporate finance initiatives.
  • Prepare and consolidate the annual operating plan, long-range plan, periodic forecasts, and monthly financial outlooks.
  • Develop executive-level presentations and financial analyses for Executive Leadership Team meetings, Board of Directors meetings, Investor Relations activities, and other corporate updates.
  • Consolidate financial information across business functions into clear, concise executive reporting.
  • Support quarterly close activities, including executive variance analyses, financial commentary, accrual reviews, and management reporting.
  • Perform enterprise-level scenario analyses, sensitivity modeling, and strategic financial evaluations.
  • Serve as the primary finance partner for Information Systems & Informatics, Finance, Legal, and People Services & Culture; support annual budgets, quarterly forecasts, long-range planning, headcount planning, capital investment planning, monthly financial reporting, variance analysis, business case development, financial decision support, and identification of financial risks and opportunities.
  • Serve as a finance partner for strategic partnerships, supporting financial planning, modeling, and decision support.
  • Develop partnership forecasts and scenario analyses, including milestone and royalty streams, cost-sharing arrangements, investments, and cash flow impacts.
  • Lead budgeting, forecasting, and reporting for partnership-related revenue and expenses, and highlight key drivers, risks, and opportunities.
  • Support enhancements to FP&A processes, models, and planning tools.
  • Support and develop the Anaplan FP&A system.
  • Drive best practices in forecasting, scenario planning, and financial reporting.
  • Partner with Accounting and IT on ERP and FP&A system optimization.

Desired Qualifications

  • CPA or MBA.
  • Prior experience supporting clinical-stage biotech or pharmaceutical research and development.
  • Anaplan experience.
  • Experience with clinical trial software such as Condor or Auxilius.
  • Experience building financial models.
  • Experience with Microsoft Dynamics 365 and business intelligence tools such as Tableau or Power BI.

About the Company

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.

Company size
501-1,000
Company stage
IPO
Headquarters
Pasadena, CA
Founded
2004

Recently Posted Jobs

Explore more opportunities at Arrowhead Pharmaceuticals

See more jobs